Ellen M. Brady
Analyst-Equity bij LifeTech Research, Inc.
Profiel
Dr. Ellen M.
Brady, MD, is Vice President of Clinical & Regulatory Research at LifeTech Research, Inc.
Dr. Brady joined LifeTech Research in 2004.
Prior to LifeTech, she spent 20 years within the pharmaceutical industry, working for both major (Sandoz, Ciba-Geigy, Janssen Pharmaceuticals and Serono) and development-stage companies (NPS Pharmaceuticals and Esperion Therapeutics).
Most recently, she was Senior Director, Clinical Research at Esperion prior to its acquisition by Pfizer.
Throughout her career, she has been responsible for the clinical development of products indicated for use in cardiology, neurology, gastroenterology, endocrinology/metabolism, HIV/AIDS and asthma.
Her responsibilities included strategic planning around clinical development, regulatory and market issues as well as the actual design and execution of clinical trial programs.
Products ranged from pre-IND to phase IV stages of development.
she is a board certified general internist with a master's degree in public health from the Johns Hopkins School of Hygiene and Public Health.
Her early career in academia focused on issues related to healthcare delivery, international health and public policy.
Currently, she has an adjunct professorship within the University of Utah College of Pharmacy.
Actieve functies van Ellen M. Brady
| Bedrijven | Functie | Begin |
|---|---|---|
LifeTech Research, Inc.
 LifeTech Research, Inc. Investment Banks/BrokersFinance Founded in 2003, LifeTech Research, Inc. is an investment research, technology development and due diligence firm located in Edgewater, Maryland. The firm provides due-diligence and business development services across the life sciences sector. They advise business development offices on product licensing and acquisition strategies and they support early-stage entrepreneurs with disruptive ideas and technologies. LifeTech also assists international financing agencies to facilitate the granting and lending of capital to improve economic welfare and societal health. LifeTech's research methods include (1) benchmarking (2) historic trend and meta-analysis (3) bias assessment and adjustment (4) decision analysis and Monte Carlo simulation (5) scenario analysis, back-testing and other statistical validation (6) advanced regression modeling and (7) risk and time-adjusted present value modeling. | Analyst-Equity | 01-01-2004 |
Eerdere bekende functies van Ellen M. Brady
| Bedrijven | Functie | Einde |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| NPS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| Serono Ltd. | Corporate Officer/Principal | - |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | - |
| Ciba-Geigy Pharmaceuticals | Corporate Officer/Principal | - |
Opleiding van Ellen M. Brady
| The Johns Hopkins University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
LifeTech Research, Inc.
LifeTech Research, Inc. Investment Banks/BrokersFinance Founded in 2003, LifeTech Research, Inc. is an investment research, technology development and due diligence firm located in Edgewater, Maryland. The firm provides due-diligence and business development services across the life sciences sector. They advise business development offices on product licensing and acquisition strategies and they support early-stage entrepreneurs with disruptive ideas and technologies. LifeTech also assists international financing agencies to facilitate the granting and lending of capital to improve economic welfare and societal health. LifeTech's research methods include (1) benchmarking (2) historic trend and meta-analysis (3) bias assessment and adjustment (4) decision analysis and Monte Carlo simulation (5) scenario analysis, back-testing and other statistical validation (6) advanced regression modeling and (7) risk and time-adjusted present value modeling. | Finance |
| Sandoz Pharmaceuticals Corp. | |
| Ciba-Geigy Pharmaceuticals | |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
| Serono Ltd. | |
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
